Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Geyer

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
American Journal of Hematology|August 18, 2018
Genomic and clinical characterization of B/T mixed phenotype acute leukemia reveals recurrent features and T-ALL like mutationsXiaoli Mi, Gabriel Griffin, Winston Lee, et al.
Haematologica|May 13, 2017
Bone marrow morphology is a strong discriminator between chronic eosinophilic leukemia, not otherwise specified and reactive idiopathic hypereosinophilic syndromeSa A Wang, Robert P Hasserjian, Wayne Tam, et al.
European Radiology|May 20, 2024
Validation of the standardization framework SSTR-RADS 1.0 for neuroendocrine tumors using the novel SSTR‑targeting peptide [<sup>18</sup>F]SiTATER Ebner, A Lohse, M P Fabritius, et al.
Frontiers in Oncology|September 16, 2021
Comparison of Multiple Clinical Testing Modalities for Assessment of NPM1-Mutant AMLAmanda Lopez, Sanjay Patel, Julia T Geyer, et al.
Cancer|November 14, 2025
Chronic myelomonocytic leukemia in the young (aged 50 years and younger): Divergent clinical and molecular characteristics from the elderlyChi Young Ok, Anuya Natu, Parnaz Daneshpajouhnejad, et al.
Blood Advances|May 16, 2019
Clinicopathologic and genetic characterization of nonacute <i>NPM1</i>-mutated myeloid neoplasmsSanjay S Patel, Caleb Ho, Ryan N Ptashkin, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 20, 2019
Clinical, immunophenotypic, and genomic findings of acute undifferentiated leukemia and comparison to acute myeloid leukemia with minimal differentiation: a study from the bone marrow pathology groupOlga K Weinberg, Robert P Hasserjian, Ezra Baraban, et al.
American Journal of Clinical Pathology|April 10, 2024
Predictors of clinical outcome in myeloproliferative neoplasm, unclassifiable: A Bone Marrow Pathology Group studyGenevieve M Crane, Julia T Geyer, Beenu Thakral, et al.
Blood Advances|September 22, 2021
Successful treatment and integrated genomic analysis of an infant with FIP1L1-RARA fusion-associated myeloid neoplasmOriana Miltiadous, Kseniya Petrova-Drus, Shipra Kaicker, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 14, 2016
Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specifiedSa A Wang, Wayne Tam, Albert G Tsai, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
American Journal of Hematology|August 18, 2018
Genomic and clinical characterization of B/T mixed phenotype acute leukemia reveals recurrent features and T-ALL like mutationsXiaoli Mi, Gabriel Griffin, Winston Lee, et al.
Haematologica|May 13, 2017
Bone marrow morphology is a strong discriminator between chronic eosinophilic leukemia, not otherwise specified and reactive idiopathic hypereosinophilic syndromeSa A Wang, Robert P Hasserjian, Wayne Tam, et al.
European Radiology|May 20, 2024
Validation of the standardization framework SSTR-RADS 1.0 for neuroendocrine tumors using the novel SSTR‑targeting peptide [<sup>18</sup>F]SiTATER Ebner, A Lohse, M P Fabritius, et al.
Frontiers in Oncology|September 16, 2021
Comparison of Multiple Clinical Testing Modalities for Assessment of NPM1-Mutant AMLAmanda Lopez, Sanjay Patel, Julia T Geyer, et al.
Cancer|November 14, 2025
Chronic myelomonocytic leukemia in the young (aged 50 years and younger): Divergent clinical and molecular characteristics from the elderlyChi Young Ok, Anuya Natu, Parnaz Daneshpajouhnejad, et al.
Blood Advances|May 16, 2019
Clinicopathologic and genetic characterization of nonacute <i>NPM1</i>-mutated myeloid neoplasmsSanjay S Patel, Caleb Ho, Ryan N Ptashkin, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 20, 2019
Clinical, immunophenotypic, and genomic findings of acute undifferentiated leukemia and comparison to acute myeloid leukemia with minimal differentiation: a study from the bone marrow pathology groupOlga K Weinberg, Robert P Hasserjian, Ezra Baraban, et al.
American Journal of Clinical Pathology|April 10, 2024
Predictors of clinical outcome in myeloproliferative neoplasm, unclassifiable: A Bone Marrow Pathology Group studyGenevieve M Crane, Julia T Geyer, Beenu Thakral, et al.
Blood Advances|September 22, 2021
Successful treatment and integrated genomic analysis of an infant with FIP1L1-RARA fusion-associated myeloid neoplasmOriana Miltiadous, Kseniya Petrova-Drus, Shipra Kaicker, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 14, 2016
Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specifiedSa A Wang, Wayne Tam, Albert G Tsai, et al.
Pageof 7